Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
34,301,232
-
Share change
-
-120,183
-
Total reported value
-
$71,016,802
-
Put/Call ratio
-
29%
-
Price per share
-
$2.07
-
Number of holders
-
67
-
Value change
-
-$353,824
-
Number of buys
-
24
-
Number of sells
-
32
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2014
As of 31 Mar 2014,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,301,232 shares.
The largest 10 holders included
Redmile Group, LLC, NEA Management Company, LLC, Palo Alto Investors, LLC, RS INVESTMENT MANAGEMENT CO LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Fund Advisors, D. E. Shaw & Co., Inc., and SOUND ENERGY PARTNERS, INC..
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.